While our models accounted for several key demographic and clinical variables, there are additional covariates—such as inflammatory markers, ART adherence, psychosocial stressors, substance use history, ART regimen, depression, and nutritional status—that may influence BDNF expression and cognitive outcomes but were not included in this analysis. This evidence concerns the gene BDNF and depressive symptom measurement.